Pharmaco-EEG: A history of progress and a missed opportunity

Clinical EEG and Neuroscience

Volumn 37, Issue 2, 2006, Pages 61-65

  Galderisi, Silvana ^a   Sannita, Walter G ^b,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOXEPIN; FENFLURAMINE; FLUVOXAMINE; HYPNOTIC AGENT; LEVONORGESTREL; MIANSERIN; MORPHINE; NEUROLEPTIC AGENT; PIRENZEPINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SCOPOLAMINE; SERTRALINE; TIAGABINE; TRANQUILIZER;

BRAIN ELECTROPHYSIOLOGY; DRUG ACTIVITY; DRUG CLASSIFICATION; DRUG DEVELOPMENT; DRUG EFFECT; DRUG STRUCTURE; DRUG TRANSPORT; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HISTORY; HUMAN; LOCOMOTION; METHODOLOGY; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PHARMACOELECTROENCEPHALOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUANTITATIVE ANALYSIS; RETINA; REVIEW; SLEEP; STATISTICAL ANALYSIS; VISUAL SYSTEM;

EID: 33646549268     PISSN: 00099155     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940603700204     Document Type: Review

References (22)

1. Fink M. Quantitative electroencephalography. II Drug patterns. In: Glaser G, (ed). EEG and Behavior. New York: Basic Books; 1963: 177-179.
2. Itil TM. Psychotropic Drugs and the Human EEG. Basel: Karger; 1974.
3. Itil TM. Anticholinergic drug-induced sleep-like EEG pattern in man. Psychopharmacologia 1969; 14(5): 383-393.
4. Fink M, Shapiro DM, Itil TM. EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers. Psychopharmacologia 1971; 22(4): 369-383.
5. Fink M, Irwin P, Weinfeld R, Schwartz M, Conney A. Blood levels and EEG effects of diazepam and bromazepam. Clin Pharm Therap 1976; 20: 184-191.
6. Matejcek M. Pharmaco-electroencephalography: the value of quantified EEG in psychopharmacology. Pharmakopsychiat 1979; 15: 126-136.
7. Sannita WG. Benefits of placebos. Nature 1995; 378: 125.
8. Sannita WG, Maggi L, Rosadini G. Effects of scopolamine (0.25-0.75 mg im) on the quantitative EEG and the neuropsychological status of healthy volunteers. Neuropsychobiology 1987; 17: 199-205.
9. Itil TM, Shapiro DM, Herrmann WM, Schulz W, Morgan V. HZI systems for EEG parametrization and classification of psychotropic drugs. Pharmakopsychiatr Neuropsychopharmakol 1979; 12: 4-19.
10. Herrmann WM, Schaerer E. Pharmaco-EEG: computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In: Lopes da Silva FH, Storm van Leeuwen W, Rėmond A, (eds). Handbook of Electroencephalography and Clinical Neurophysiology. Amsterdam: Elsevier; 1982; 2: 385-445.
11. Saletu B. The use of phamnaco-EEG in drug profiling. In: Hindmarch I, Stonier PD, (eds). Human Psychopharmacology Measures and Methods. New York: John Wiley; 1987; 1: 173-200.
12. Itil TM. The discovery of antidepressant drugs by computer-analyzed human cerebral bio-electrical potentials (CEEG). Prog Neurobiol 1983; 20(3-4): 185-249.
13. Itil TM, Cora R, Akpinar S, Herrmann WM, Patterson CJ. "Psychotropic" action of sex hormones: computerized EEG in establishing the immediate CNS effects of steroid hormones. Curr Ther Res Clin Exp 1974; 16(11): 1147-1170.
14. Fink M, Irwin P. Central nervous system effects of aspirin. Clin Pharmacol Ther 1982; 32(3): 362-365.
15. Lopes da Silva F. Pharmaco-EEG: from cellular to the network level. EEG beta spectral power as a biomarker for GABAergic inhibition and its role in the assessment of AEDs. Methods Find Exp Clin Pharmacol 2002; 24(suppl D): 3.
16. International Pharmaco-EEG group (IPEG). Recommendations for EEG and evoked potential mapping. Neuropsychobiology 1989; 22(3): 170-176.
17. Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Meth Inform Med 1987; 26: 77-88.
18. Lehmann D, Wackermann J, Michel CM, Koenig T. Space-oriented EEG segmentation reveals changes in brain electric field maps under the influence of a nootropic drug. Psychiatry Res 1993; 50(4): 275-282.
19. Wackermann J, Lehmann D, Dvorak I, Michel CM. Global dimensional complexity of multi-channel EEG indicates change of human brain functional state after a single dose of a nootropic drug. Electroencephalogr Clin Neurophysiol 1993; 86(3): 193-198.
20. Saletu B, Anderer P, Kinsperger K, Grunberger J. Topographic brain mapping of EEG in neuropsychopharmacology. II. Clinical applications (pharmaco EEG imaging). Methods Find Exp Clin Pharmacol 1987; 9: 385-408.
21. Maurer K, Dierks T, Laux G, Rupprecht R, Ihl R. Topographic mapping of EEG and auditory evoked P300 in neuropsychopharmacology (topographic pharmaco-EEG and pharmaco-AEP 300). Pharmacopsychiatry 1988; 21(6): 338-342.
22. Pascual-Marqui RD. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol 2002; 24(suppl D): 5-12.